Dong Xu

2.1k total citations · 1 hit paper
53 papers, 1.8k citations indexed

About

Dong Xu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Dong Xu has authored 53 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 24 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Dong Xu's work include RNA modifications and cancer (13 papers), MicroRNA in disease regulation (9 papers) and Cancer-related molecular mechanisms research (9 papers). Dong Xu is often cited by papers focused on RNA modifications and cancer (13 papers), MicroRNA in disease regulation (9 papers) and Cancer-related molecular mechanisms research (9 papers). Dong Xu collaborates with scholars based in China, United States and Netherlands. Dong Xu's co-authors include Honggang Cui, Meihua Sui, Jinqiang Wang, Weiwei Mao, Youqing Shen, Weilin Sun, Jianbin Tang, Lye Lin Lock, Yasu Jiang and Xianchen Liu and has published in prestigious journals such as ACS Nano, PLoS ONE and Scientific Reports.

In The Last Decade

Dong Xu

52 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Role of Micelle Size in Tumor Accumulation, Penetration, and Treatment

2015 572 citations Dong Xu et al. profile →

Peers

Countries citing papers authored by Dong Xu

Since Specialization

Citations

This map shows the geographic impact of Dong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong Xu more than expected).

Fields of papers citing papers by Dong Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong Xu. The network helps show where Dong Xu may publish in the future.

Co-authorship network of co-authors of Dong Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Dong Xu. A scholar is included among the top collaborators of Dong Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong Xu. Dong Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Wild-Type p53 Regulates Apoptosis of Human Breast Cancer Cells 2024 ·Discovery Medicine ·Xuliang Zhang, (unknown), Lei Cai, Jian Ming, (unknown), Dong Xu	2
2	Methotrexate-loaded hyaluronan-modified liposomes integrated into dissolving microneedles for the treatment of psoriasis 2024 ·European Journal of Pharmaceutical Sciences ·(unknown), (unknown), Dong Xu, Min Fang, (unknown), Tong Zhu, Qingliang Yang, Jing Xie, Qinying Yan	26
3	α-Conotoxin recombinant protein ImI-AFP3 efficiently inhibits the growth and migration of lung cancer cells 2023 ·Protein Expression and Purification ·Xiaobing Chen, (unknown), Wei Li, Dong Xu, Yi Chen, Yan Lu, Mingyue Zhu, Mengsen Li, Bo Lin	0
4	The differentiation of colorectal cancer is closely relevant to m6A modification 2021 ·Biochemical and Biophysical Research Communications ·Shuai Wang, Xiaoyan Fan, Jun Zhu, Dong Xu, Ruikai Li, Rujie Chen, (unknown), Yao Shen, Jun Hao, Ke Wang, (unknown), Yaofeng Wang, Yu Jiang, Jipeng Li, Jian Zhang	20
5	Effect of miR-126 on the Proliferation and Migration of Vascular Smooth Muscle Cells in Aortic Aneurysm Mice Under PI3K/AKT/mTOR Signaling Pathway 2021 ·Molecular Biotechnology ·(unknown), Xin Fang, (unknown), Yongchang Liu, Dong Xu, (unknown), (unknown)	4
6	Alpha-Fetoprotein Binding Mucin and Scavenger Receptors: An Available Bio-Target for Treating Cancer 2021 ·Frontiers in Oncology ·Bo Lin, (unknown), (unknown), Dong Xu, Mingyue Zhu, Mengsen Li	10
7	Identification of a robust signature for clinical outcomes and immunotherapy response in gastric cancer: based on N6-methyladenosine related long noncoding RNAs 2021 ·Cancer Cell International ·(unknown), Dong Xu, Jun Zhu, Jipeng Li, Lei Liu, Yanchun Deng	18
8	LncRNA DLEU1 Contributes to the Growth and Invasion of Colorectal Cancer via Targeting miR-320b/PRPS1 2021 ·Frontiers in Oncology ·Dong Xu, Fei Yang, (unknown), (unknown), Jianfei Wen, (unknown), Xiaoyan Ding, Hongbao Yang	11
9	CircSKA3 Modulates FOXM1 to Facilitate Cell Proliferation, Migration, and Invasion While Confine Apoptosis in Medulloblastoma via miR-383-5p 2020 ·Cancer Management and Research ·Xinfang Wang, Dong Xu, (unknown), Yingying Zhang, Yuling Zhang, (unknown), Ying Li	15
10	Changes in lipid profiles during and after (neo)adjuvant chemotherapy in women with early-stage breast cancer: A retrospective study 2019 ·PLoS ONE ·Wei Tian, Yihan Yao, (unknown), Yunxiang Zhou, (unknown), Dong Xu, Yongchuan Deng	38
11	Ropivacaine regulates the expression and function of heme oxygenase-1 2018 ·Biomedicine & Pharmacotherapy ·(unknown), Yu Li, (unknown), Dong Xu, Yajie Zhang, (unknown)	6
12	Purification and characterization of a bioactive alpha-fetoprotein produced by HEK-293 cells 2017 ·Protein Expression and Purification ·Bo Lin, (unknown), (unknown), Wei Li, Dong Xu, Yi Chen, Yan Lu, Qiaoyun Wang, Xieju Xie, Mingyue Zhu, Mengsen Li	5
13	FTO expression is associated with the occurrence of gastric cancer and prognosis 2017 ·Oncology Reports ·Dong Xu, Weiwei Shao, Yasu Jiang, Xi Wang, Ying Liu, Xianchen Liu	137
14	mTOR signaling pathway is inhibited downstream of the cyclophilin D-mediated mitochondrial permeability transition in honokiol-triggered regulated necrosis 2016 ·Molecular Medicine Reports ·Wei Tian, (unknown), (unknown), Dong Xu, Hong Shen, Yongchuan Deng	4
15	Upregulation of SNHG6 regulates ZEB1 expression by competitively binding miR-101-3p and interacting with UPF1 in hepatocellular carcinoma 2016 ·Cancer Letters ·Lei Chang, Yufeng Yuan, Cuicui Li, Tao Guo, Haolong Qi, Yusha Xiao, Dong Xu, Zhisu Liu, Quanyan Liu	129
16	MicroRNA-195 regulates steroid receptor coactivator-3 protein expression in hepatocellular carcinoma cells 2014 ·Tumor Biology ·Honglei Jiang, Hao Yu, Xu Ma, Dong Xu, Guofu Lin, (unknown), Junzhe Jin	16
17	LPS Induced miR-181a Promotes Pancreatic Cancer Cell Migration via Targeting PTEN and MAP2K4 2014 ·Digestive Diseases and Sciences ·Jianhui Liu, Dong Xu, Qingguang Wang, Datong Zheng, (unknown), Li Xu	66
18	hsa-miR-141 downregulates TM4SF1 to inhibit pancreatic cancer cell invasion and migration 2013 ·International Journal of Oncology ·Li Xu, Qiang Li, Dong Xu, Qingguang Wang, Yong An, Qing Du, Jingjing Zhang, Yi Zhu, (unknown)	61
19	Overexpression of serine/threonine-protein kinase-1 in pancreatic cancer tissue: Serine/threonine-protein kinase-1 knockdown increases the chemosensitivity of pancreatic cancer cells 2012 ·Molecular Medicine Reports ·Qingguang Wang, Dong Xu, Chao Han, Min Tu, Qing Du, Jingjing Zhang, Yi Zhu, Li Xu	4
20	Increased CD147 and MMP-9 expression in the normal rat brain after gamma irradiation 2012 ·Journal of Radiation Research ·Han Li, Wei Meng, Sen Li, Ziwei Zhou, Dong Xu	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact